{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["anti-cancer activity", "l-amino acid", "tetrandrine derivatives", "urea"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "32283819", "DateCompleted": {"Year": "2021", "Month": "01", "Day": "06"}, "DateRevised": {"Year": "2021", "Month": "01", "Day": "06"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "04", "Day": "09"}], "Language": ["eng"], "ELocationID": ["1738", "10.3390/molecules25071738"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "25", "Issue": "7", "PubDate": {"Year": "2020", "Month": "Apr", "Day": "09"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Design, Synthesis of Novel Tetrandrine-14-l-Amino Acid and Tetrandrine-14-l-Amino Acid-Urea Derivatives as Potential Anti-Cancer Agents.", "Abstract": {"AbstractText": ["Tetrandrine, a dibenzyltetrahydroisoquinoline alkaloid isolated from the root of the traditional Chinese medicinal plant <i>Stephania tetrandra</i> S. Moore, a member of the Menispermaceae, showed anti-cancer activity by inhibiting cell proliferation, preventing cell cycle progress and induction of cell death and autophagy. In this study, twelve tetrandrine-l-amino acid derivatives and twelve tetrandrine-14-l-amino acid-urea derivatives were designed and synthesized, using C14-aminotetrandrine as raw material. Then the preliminary in vitro anti-cancer activities of these derivatives against human breast cancer cell line MDA-MB-231, human leukemia cell lines HEL and K562 were evaluated. The in vitro cytotoxicity results showed that these derivatives exhibited potent inhibitory effects on cancer cell growth, and the primary structure-activity relationships were evaluated. Notably, compound <b>3f</b> exhibited satisfactory anticancer activity against all three cancer cell lines, especially the HEL cell line, with the IC<sub>50</sub> value of 0.23 \u00b5M. Further research showed that <b>3f</b> could induce G1/S cycle arrest and apoptosis in a dose- and time- dependent manner on the leukemia cell line HEL. The results suggested that <b>3f</b> may be used as a potential anti-cancer agent for human leukemia."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Zunyi Medical University, Zunyi 563000, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, Guiyang 550014, China."}], "LastName": "Hu", "ForeName": "Sheng-Cao", "Initials": "SC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Zunyi Medical University, Zunyi 563000, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, Guiyang 550014, China."}], "LastName": "Yang", "ForeName": "Jin", "Initials": "J"}, {"Identifier": ["0000-0002-0378-0589"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, Guiyang 550014, China."}], "LastName": "Chen", "ForeName": "Chao", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, Guiyang 550014, China."}], "LastName": "Song", "ForeName": "Jun-Rong", "Initials": "JR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Zunyi Medical University, Zunyi 563000, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, Guiyang 550014, China."}], "LastName": "Pan", "ForeName": "Wei-Dong", "Initials": "WD"}], "GrantList": [{"GrantID": "81960635", "Agency": "National Natural Science Foundation of China", "Country": ""}, {"GrantID": "81360479", "Agency": "National Natural Science Foundation of China", "Country": ""}, {"GrantID": "U1812403", "Agency": "National Natural Science Foundation of China", "Country": ""}, {"GrantID": "QKHRC[2016]4037", "Agency": "Guizhou Science and Technology Department", "Country": ""}, {"GrantID": "QKHPTRC[2017]5737", "Agency": "Guizhou Science and Technology Department", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Amino Acids"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Benzylisoquinolines"}, {"RegistryNumber": "29EX23D5AJ", "NameOfSubstance": "tetrandrine"}, {"RegistryNumber": "8W8T17847W", "NameOfSubstance": "Urea"}], "MeshHeadingList": [{"QualifierName": ["chemistry"], "DescriptorName": "Amino Acids"}, {"QualifierName": ["chemical synthesis", "chemistry", "pharmacology"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": ["chemistry"], "DescriptorName": "Benzylisoquinolines"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Survival"}, {"QualifierName": [], "DescriptorName": "Chemistry Techniques, Synthetic"}, {"QualifierName": [], "DescriptorName": "Drug Design"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Inhibitory Concentration 50"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}, {"QualifierName": ["chemistry"], "DescriptorName": "Urea"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Bray F., Ferlay J., Soerjomataram I., Siegel R.L., Torre L.A., Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018;68:394\u2013424. doi: 10.3322/caac.21492.", "ArticleIdList": ["10.3322/caac.21492", "30207593"]}, {"Citation": "Miller K.D., Siegel R.L., Lin C.C., Mariotto A.B., Kramer J.L., Rowland J.H., Stein K.D., Alteri R., Jemal A. Cancer treatment and survivorship statistics, 2016. CA Cancer J. Clin. 2016;66:271\u2013289. doi: 10.3322/caac.21349.", "ArticleIdList": ["10.3322/caac.21349", "27253694"]}, {"Citation": "Chabner B.A., Roberts T.G. Timeline: Chemotherapy and the war on cancer. Nat. Rev. Cancer. 2005;5:65\u201372. doi: 10.1038/nrc1529.", "ArticleIdList": ["10.1038/nrc1529", "15630416"]}, {"Citation": "Sternberg C.N., Donat S.M., Bellmunt J., Millikan R.E., Stadler W., De Mulder P., Sherif A., von der Maase H., Tsukamoto T., Soloway M.S. Chemotherapy for bladder cancer: Treatment guidelines for neoadjuvant chemotherapy, bladder preservation, adjuvant chemotherapy, and metastatic cancer. Urology. 2007;69:62\u201379. doi: 10.1016/j.urology.2006.10.041.", "ArticleIdList": ["10.1016/j.urology.2006.10.041", "17280909"]}, {"Citation": "Zagouri F., Peroukidis S., Tzannis K., Kouloulias V., Bamias A. Hellenic Genito-Urinary Cancer, G., Current clinical practice guidelines on chemotherapy and radiotherapy for the treatment of non-metastatic muscle-invasive urothelial cancer: A systematic review and critical evaluation by the Hellenic Genito-Urinary Cancer Group (HGUCG) Crit. Rev. Oncol. Haematol. 2015;93:36\u201349.", "ArticleIdList": ["25205597"]}, {"Citation": "Newman D.J., Cragg G.M., Snader K.M. Natural products as sources of new drugs over the period 1981-2002. J. Nat. Prod. 2003;66:1022\u20131037. doi: 10.1021/np030096l.", "ArticleIdList": ["10.1021/np030096l", "12880330"]}, {"Citation": "Mann J. Natural products in cancer chemotherapy: Past, present and future. Nat. Rev. Cancer. 2002;2:143\u2013148. doi: 10.1038/nrc723.", "ArticleIdList": ["10.1038/nrc723", "12635177"]}, {"Citation": "Cragg G.M., Newman D.J. Plants as a source of anti-cancer agents. J. Ethnopharmacol. 2005;100:72\u201379. doi: 10.1016/j.jep.2005.05.011.", "ArticleIdList": ["10.1016/j.jep.2005.05.011", "16009521"]}, {"Citation": "Surh Y.J. Cancer chemoprevention with dietary phytochemicals. Nat. Rev. Cancer. 2003;3:768\u2013780. doi: 10.1038/nrc1189.", "ArticleIdList": ["10.1038/nrc1189", "14570043"]}, {"Citation": "Chikara S., Nagaprashantha L.D., Singhal J., Horne D., Awasthi S., Singhal S.S. Oxidative stress and dietary phytochemicals: Role in cancer chemoprevention and treatment. Cancer lett. 2018;413:122\u2013134. doi: 10.1016/j.canlet.2017.11.002.", "ArticleIdList": ["10.1016/j.canlet.2017.11.002", "29113871"]}, {"Citation": "Fabricant D.S., Farnsworth N.R. The value of plants used in traditional medicine for drug discovery. Environ. Health perspect. 2001;109:69\u201375.", "ArticleIdList": ["PMC1240543", "11250806"]}, {"Citation": "Bhagya N., Chandrashekar K.R. Tetrandrine--A molecule of wide bioactivity. Phytochemistry. 2016;125:5\u201313. doi: 10.1016/j.phytochem.2016.02.005.", "ArticleIdList": ["10.1016/j.phytochem.2016.02.005", "26899361"]}, {"Citation": "Liu T., Zhang Z., Yu C., Zeng C., Xu X., Wu G., Huang Z., Li W. Tetrandrine antagonizes acute megakaryoblastic leukaemia growth by forcing autophagy-mediated differentiation. Br. J. Pharmacol. 2017;174:4308\u20134328. doi: 10.1111/bph.14031.", "ArticleIdList": ["10.1111/bph.14031", "PMC5715583", "28901537"]}, {"Citation": "Wong V.K.W., Zeng W., Chen J., Yao X.J., Leung E.L.H., Wang Q.Q., Chiu P., Ko B.C.B., Law B.Y.K. Tetrandrine, an activator of autophagy, induces autophagic cell death via PKC-alpha inhibition and mTOR-dependent mechanisms. Front. Pharmacol. 2017 doi: 10.3389/fphar.2017.00351.", "ArticleIdList": ["10.3389/fphar.2017.00351", "PMC5462963", "28642707"]}, {"Citation": "Meng L.H., Zhang H., Hayward L., Takemura H., Shao R.G., Pommier Y. Tetrandrine induces early G1 arrest in human colon carcinoma cells by down-regulating the activity and inducing the degradation of G1-S-specific cyclin-dependent kinases and by inducing p53 and p21Cip1. Cancer Res. 2004;64:9086\u20139092. doi: 10.1158/0008-5472.CAN-04-0313.", "ArticleIdList": ["10.1158/0008-5472.CAN-04-0313", "15604277"]}, {"Citation": "Xiao W., Jiang Y., Men Q., Yuan L., Huang Z., Liu T., Li W., Liu X. Tetrandrine induces G1/S cell cycle arrest through the ROS/Akt pathway in EOMA cells and inhibits angiogenesis in vivo. Int. J. Oncol. 2015;46:360\u2013368. doi: 10.3892/ijo.2014.2735.", "ArticleIdList": ["10.3892/ijo.2014.2735", "25355542"]}, {"Citation": "Lee J.H., Kang G.H., Kim K.C., Kim K.M., Park D.I., Choi B.T., Kang H.S., Lee Y.T., Choi Y.H. Tetrandrine-induced cell cycle arrest and apoptosis in A549 human lung carcinoma cells. Int. J. Oncol. 2002;21:1239\u20131244. doi: 10.3892/ijo.21.6.1239.", "ArticleIdList": ["10.3892/ijo.21.6.1239", "12429973"]}, {"Citation": "Li X., Su B., Liu R., Wu D., He D. Tetrandrine induces apoptosis and triggers caspase cascade in human bladder cancer cells. J. Surg. Res. 2011;166:45\u201351. doi: 10.1016/j.jss.2010.10.034.", "ArticleIdList": ["10.1016/j.jss.2010.10.034", "21176918"]}, {"Citation": "Wang H., Liu T., Li L., Wang Q., Yu C., Liu X., Li W. Tetrandrine is a potent cell autophagy agonist via activated intracellular reactive oxygen species. Cell Biosci. 2015;4:4\u201312. doi: 10.1186/2045-3701-5-4.", "ArticleIdList": ["10.1186/2045-3701-5-4", "PMC4429611", "25973171"]}, {"Citation": "Liu W., Kou B., Ma Z.K., Tang X.S., Lv C., Ye M., Chen J.Q., Li L., Wang X.Y., He D.L. Tetrandrine suppresses proliferation, induces apoptosis, and inhibits migration and invasion in human prostate cancer cells. Asian J. Androl. 2015;17:850\u2013853.", "ArticleIdList": ["PMC4577603", "25677131"]}, {"Citation": "Xu W.L., Shen H.L., Ao Z.F., Chen B.A., Xia W., Gao F., Zhang Y.N. Combination of tetrandrine as a potential-reversing agent with daunorubicin, etoposide and cytarabine for the treatment of refractory and relapsed acute myelogenous leukemia. Leuk. Res. 2006;30:407\u2013413. doi: 10.1016/j.leukres.2005.08.005.", "ArticleIdList": ["10.1016/j.leukres.2005.08.005", "16219352"]}, {"Citation": "Fu L.W., Zhang Y.M., Liang Y.J., Yang X.P., Pan Q.C. The multidrug resistance of tumour cells was reversed by tetrandrine in vitro and in xenografts derived from human breast adenocarcinoma MCF-7/adr cells. Eur. J. Cancer. 2002;38:418\u2013426. doi: 10.1016/S0959-8049(01)00356-2.", "ArticleIdList": ["10.1016/S0959-8049(01)00356-2", "11818209"]}, {"Citation": "Sun Y.F., Wink M. Tetrandrine and fangchinoline, bisbenzylisoquinoline alkaloids from Stephania tetrandra can reverse multidrug resistance by inhibiting P-glycoprotein activity in multidrug resistant human cancer cells. Phytomedicine. 2014;21:1110\u20131119. doi: 10.1016/j.phymed.2014.04.029.", "ArticleIdList": ["10.1016/j.phymed.2014.04.029", "24856768"]}, {"Citation": "Wu C.Z., Lai L., Hu X., Lei R.R., Yang Y.F. Synthesis and antitumor activity of tetrandrine derivatives. J. Asian Nat. Prod. Res. 2013;15:993\u20131002. doi: 10.1080/10286020.2013.823950.", "ArticleIdList": ["10.1080/10286020.2013.823950", "23944846"]}, {"Citation": "Niu N., Qu T., Xu J., Lu X., Bodwell G.J., Zhao Z. Synthesis of 5-alkynyltetrandrine derivatives and evaluation of their anticancer activity on A549 cell lines. Anticancer Agents Med. Chem. 2019;19:1454\u20131462. doi: 10.2174/1871520619666190408132249.", "ArticleIdList": ["10.2174/1871520619666190408132249", "30961510"]}, {"Citation": "Wei X., Qu T.L., Yang Y.F., Xu J.F., Li X.W., Zhao Z.B., Guo Y.W. Design and synthesis of new tetrandrine derivatives and their antitumor activities. J. Asian Nat. Prod. Res. 2016;18:966\u2013975. doi: 10.1080/10286020.2016.1188085.", "ArticleIdList": ["10.1080/10286020.2016.1188085", "27244089"]}, {"Citation": "Shi C., Ahmad Khan S., Wang K., Schneider M. Improved delivery of the natural anticancer drug tetrandrine. Int. J. Pharm. 2015;479:41\u201351. doi: 10.1016/j.ijpharm.2014.12.022.", "ArticleIdList": ["10.1016/j.ijpharm.2014.12.022", "25510598"]}, {"Citation": "Hagiwara M., Adachi-Akahane S., Nagao T. High-affinity binding of [3H] DTZ323 to the diltiazem-binding site of L-type Ca2+ channels. Eur. J. Pharm. 2003;466:63\u201371. doi: 10.1016/S0014-2999(03)01547-4.", "ArticleIdList": ["10.1016/S0014-2999(03)01547-4", "12679142"]}, {"Citation": "Lan J.J., Wang N., Huang L., Liu Y.Z., Ma X.P., Lou H.Y., Chen C., Feng Y.B., Pan W.D. Design and synthesis of novel tetrandrine derivatives as potential anti-tumor agents against human hepatocellular carcinoma. Eur. J. Med. Chem. 2017;127:554\u2013566. doi: 10.1016/j.ejmech.2017.01.008.", "ArticleIdList": ["10.1016/j.ejmech.2017.01.008", "28109948"]}, {"Citation": "Lan J.J., Huang L., Lou H.Y., Chen C., Liu T.J.J., Hu S.C., Yao Y., Song J.R., Luo J., Liu Y.Z., et al. Design and synthesis of novel C14-urea-tetrandrine derivatives with potent anti-cancer activity. Eur. J. Med. Chem. 2018;143:1968\u20131980. doi: 10.1016/j.ejmech.2017.11.007.", "ArticleIdList": ["10.1016/j.ejmech.2017.11.007", "29133049"]}, {"Citation": "Song J.R., Lan J.J., Chen C., Hu S.C., Song J.R., Liu W., Zeng X.Y., Lou H.Y., Ben-David Y., Pan W.D. Design, synthesis and bioactivity investigation of tetrandrine derivatives as potential anti-cancer agents. Med. Chem. Comm. 2018;9:1131\u20131141. doi: 10.1039/C8MD00125A.", "ArticleIdList": ["10.1039/C8MD00125A", "PMC6072089", "30109000"]}, {"Citation": "Liu R., Wang S., Fang S., Wang J., Chen J., Huang X., He X., Liu C. Liquid Crystalline Nanoparticles as an Ophthalmic Delivery System for Tetrandrine: Development, Characterization, and In Vitro and In Vivo Evaluation. Nanoscale Res. Lett. 2016 doi: 10.1186/s11671-016-1471-0.", "ArticleIdList": ["10.1186/s11671-016-1471-0", "PMC4870510", "27188974"]}, {"Citation": "Tian Y., Yin H., Xu H. Enhanced Pro-Apoptotic Effect of Tetrandrine Loaded Nanoparticles Against Osteosarcoma Cells. Curr. Drug Deliv. 2016;13:946\u2013952. doi: 10.2174/1567201813666160303104439.", "ArticleIdList": ["10.2174/1567201813666160303104439", "26935259"]}, {"Citation": "Vale N., Ferreira A., Matos J., Fresco P., Gouveia M.J. Amino acids in the development of prodrugs. Molecules. 2018;23:2318. doi: 10.3390/molecules23092318.", "ArticleIdList": ["10.3390/molecules23092318", "PMC6225300", "30208629"]}, {"Citation": "Gonzalez D.E., Covitz K.M., Sadee W., Mrsny R.J. An oligopeptide transporter is expressed at high levels in the pancreatic carcinoma cell lines AsPc-1 and Capan-2. Cancer Res. 1998;58:519\u2013525.", "ArticleIdList": ["9458100"]}, {"Citation": "Buckley S.T., Fischer S.M., Fricker G., Brandl M. In vitro models to evaluate the permeability of poorly soluble drug entities: Challenges and perspectives. Eur. J. Pharm. Sci. 2012;45:235\u2013250. doi: 10.1016/j.ejps.2011.12.007.", "ArticleIdList": ["10.1016/j.ejps.2011.12.007", "22178532"]}, {"Citation": "Nakanishi T., Tamai I., Takaki A., Tsuji A. Cancer cell-targeted drug delivery utilizing oligopeptide transport activity. Int. J. Cancer. 2000;88:274\u2013280. doi: 10.1002/1097-0215(20001015)88:2<274::AID-IJC20>3.0.CO;2-5.", "ArticleIdList": ["10.1002/1097-0215(20001015)88:2<274::AID-IJC20>3.0.CO;2-5", "11004680"]}, {"Citation": "Vig B.S., Lorenzi P.J., Mittal S., Landowski C.P., Shin H.C., Mosberg H.I., Hilfinger J.M., Amidon G.L. Amino acid ester prodrugs of floxuridine: Synthesis and effects of structure, stereochemistry, and site of esterification on the rate of hydrolysis. Pharm. Res. 2003;20:1381\u20131388. doi: 10.1023/A:1025745824632.", "ArticleIdList": ["10.1023/A:1025745824632", "14567631"]}, {"Citation": "Landowski C.P., Lorenzi P.L., Song X., Amidon G.L. Nucleoside ester prodrug substrate specificity of liver carboxylesterase. J. Pharm. Exp. Ther. 2006;316:572\u2013580. doi: 10.1124/jpet.105.092726.", "ArticleIdList": ["10.1124/jpet.105.092726", "16223870"]}, {"Citation": "Vig B.S., Huttunen K.M., Laine K., Rautio J. Amino acids as promoieties in prodrug design and development. Adv. Drug Deliv. Rev. 2013;65:1370\u20131385. doi: 10.1016/j.addr.2012.10.001.", "ArticleIdList": ["10.1016/j.addr.2012.10.001", "23099277"]}, {"Citation": "Diaz-Padilla I., Siu L.L. Brivanib alaninate for cancer. Expert Opin. Investig. Drugs. 2011;20:577\u2013586. doi: 10.1517/13543784.2011.565329.", "ArticleIdList": ["10.1517/13543784.2011.565329", "21391890"]}, {"Citation": "Li H.Q., Lv P.C., Yan T., Zhu H.L. Urea derivatives as anticancer agents. Anticancer Agents Med. Chem. 2009;9:471\u2013480. doi: 10.2174/1871520610909040471.", "ArticleIdList": ["10.2174/1871520610909040471", "19442045"]}, {"Citation": "Liu Y.Z., Xia B., Lan J.J., Hu S.C., Huang L., Chen C., Zeng X.Y., Lou H.Y., Lin C.H., Pan W.D. Design, synthesis and anticancer evaluation of fangchinoline derivatives. Molecules. 2017;22:1923. doi: 10.3390/molecules22111923.", "ArticleIdList": ["10.3390/molecules22111923", "PMC6150242", "29117113"]}, {"Citation": "Yang J., Hu S.C., Wang C.L., Song J.R., Chen C., Fan Y.H., Ben-David Y., Pan W.D. Fangchinoline derivatives induce cell cycle arrest and apoptosis in human leukemia cell lines via suppression of the PI3K/AKT and MAPK signaling pathway. Eur. J. Med. Chem. 2020;186:1898\u20131910. doi: 10.1016/j.ejmech.2019.111898.", "ArticleIdList": ["10.1016/j.ejmech.2019.111898", "31784186"]}]}], "History": [{"Year": "2020", "Month": "3", "Day": "6"}, {"Year": "2020", "Month": "3", "Day": "26"}, {"Year": "2020", "Month": "3", "Day": "31"}, {"Year": "2020", "Month": "4", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "4", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "1", "Day": "7", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "4", "Day": "9"}], "PublicationStatus": "epublish", "ArticleIdList": ["32283819", "PMC7180913", "10.3390/molecules25071738", "molecules25071738"]}}]}